Procept Biorobotics Corp (PRCT) Stock Price, Quote & News

Company Profile

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 232 7200

Website: www.procept-biorobotics.com

Address:

150 Baytech Drive, San Jose, United States

Aultreras13 Sep. 9 at 1:50 PM

$AMRC $AXL $PRCT $ULCC $ZS

0 · Reply

NVDAMillionaire Sep. 5 at 9:09 PM

$PRCT Great piece that accurately captures PRCT's current position. So if you want to refresh your understanding of PRCT or learn about PRCT for the first time, this is essential reading. https://beyondspx.com/quote/PRCT/procept-biorobotics-robotic-precision-expanding-horizons-and-a-clearer-path-to-profitability-nasdaq-prct#analysis

0 · Reply

JasonCO Sep. 5 at 6:27 PM

$PRCT nice move from $37. Do t forget to dump or yo gonna get dumped on

1 · Reply

stockstelegraph Sep. 4 at 3:07 PM

🚀 Top Analyst Upgrades You Shouldn’t Miss! Big upside + high conviction = opportunity. 🧠💸 🔹 $ULCC: +46.39% Upside | PT: $8 | Accuracy: 74% 🔹 $PRCT: +58.50% Upside | PT: $60 | Accuracy: 67% 🔹 $AXL: +32.89% Upside | PT: $53 | Accuracy: 71% 🔹 $AMRC: +36.05% Upside | PT: $33 | Accuracy: 76% 🔹 $ZS: +19.16% Upside | PT: $320 | Accuracy: 68% Upgraded by firms like Deutsche Bank, Oppenheimer & Morgan Stanley 📈 via @stockstelegraph #StocksToWatch #AnalystRatings #PriceTarget #StockMarket #Investing

0 · Reply

sirspanky Sep. 4 at 12:57 PM

$HCTI 🚨 Big news for $HCTI! 🚨 Part 1 the facts Ezovion (HCTI subsidiary) + TRIMED just cleared all 4 phases of NPHIES certification in Saudi Arabia ✅ (eligibility, claims, payments, etc). This officially opens the door to the Saudi healthcare market, a multi-B sector under Vision 2030. This isn’t hype—it’s proof $HCTI’s acquisitions are firing. Certification = sticky SaaS contracts, recurring rev, & international expansion 🌍. Add Q2 turnaround momentum + compliance locked in = primed for a major rerate 📈. Hidden in plain sight. Oversold now, but smart money sees the setup. #AI #HealthTech #HCTI $BBAI $SOUN $PRCT

1 · Reply

Thelonius_Stonk Sep. 3 at 5:23 PM

$PRCT show me 27s

1 · Reply

TipRanks Sep. 3 at 10:16 AM

‘Your Move, Human’: Analysts See Growth Potential in These 2 Robotics Stocks https://www.tipranks.com/news/article/your-move-human-analysts-see-growth-potential-in-these-2-robotics-stocks $SERV $PRCT

0 · Reply

stockstelegraph Sep. 2 at 2:23 PM

🚨 Analyst upgrades to watch (Sept 2): $AXL 🚗 American Axle – RBC: Sector Perform → Buy, PT $6 → $8 (+33%) $PRCT 🩺 PROCEPT BioRobotics – Oppenheimer: Perform → Outperform, PT $60 (+44%) $AMG 💼 Affiliated Managers – BofA: Neutral → Buy, PT $236 → $331 (+44%) $AMRC ⚡ Ameresco – Baird: Neutral → Outperform, PT $23 → $35 (+36%) $HXL 🛩️ Hexcel – UBS: Neutral → Buy, PT $82 (+22%) Wall St. turns bullish 📈🔥 via @stockstelegraph #Stocks #Investing #Trading #StockMarket #WallStreet

0 · Reply

Muddymac Sep. 2 at 1:39 PM

$PRCT Added some more. In a quarter or two, the $40S will be in the rear view.

0 · Reply

MaverikIT Sep. 2 at 1:36 PM

$UTHR $ONC - very nice $PRCT $ARWR

0 · Reply

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy

Aug 7, 2025, 2:17 AM EDT - 4 weeks ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:03 PM EDT - 4 weeks ago

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Jul 24, 2025, 6:00 PM EDT - 6 weeks ago

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

Jul 23, 2025, 8:00 AM EDT - 6 weeks ago

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

Jul 21, 2025, 4:03 PM EDT - 7 weeks ago

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 14, 2025, 9:15 PM EDT - 2 months ago

Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

May 17, 2025, 7:00 AM EDT - 4 months ago

19 stocks at the intersection of AI and robotics that could see big sales boosts

AI AMBA CLS HSAI IOT ISRG NOW

Apr 29, 2025, 4:03 PM EDT - 4 months ago

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

Apr 24, 2025, 4:03 PM EDT - 4 months ago

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

Apr 24, 2025, 2:37 PM EDT - 4 months ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 7:00 AM EDT - 4 months ago

PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 10, 2025, 4:03 PM EDT - 5 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

Mar 24, 2025, 8:00 AM EDT - 6 months ago

WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation

Mar 14, 2025, 8:00 AM EDT - 6 months ago

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada

Mar 11, 2025, 4:42 AM EDT - 6 months ago

Procept BioRobotics: Strong Growth, But Profitability Seems Far Away

Feb 25, 2025, 4:02 PM EST - 7 months ago

PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 8:00 AM EST - 7 months ago

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Jan 16, 2025, 9:00 AM EST - 8 months ago

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

Nov 26, 2024, 4:05 PM EST - 10 months ago

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Nov 26, 2024, 5:10 AM EST - 10 months ago

Procept BioRobotics: Continued Growth Runway Ahead

Oct 29, 2024, 8:43 PM EDT - 11 months ago

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

Oct 28, 2024, 4:19 PM EDT - 11 months ago

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

Oct 28, 2024, 2:17 PM EDT - 11 months ago

Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential

Oct 28, 2024, 10:32 AM EDT - 11 months ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 7:00 AM EDT - 11 months ago

PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance

Oct 9, 2024, 4:04 PM EDT - 11 months ago

PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 7, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer

Aug 28, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval

Aug 21, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

Aug 3, 2024, 9:23 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance

Jul 15, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 17, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

Jun 3, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

May 13, 2024, 4:05 PM EDT - 1 year ago

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

May 6, 2024, 8:00 AM EDT - 1 year ago

Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia

May 1, 2024, 12:56 PM EDT - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q1 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 1 year ago

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Apr 23, 2024, 8:00 AM EDT - 1 year ago

PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting

Apr 4, 2024, 4:04 PM EDT - 1 year ago

PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas

Apr 2, 2024, 4:03 PM EDT - 1 year ago

PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024

Feb 28, 2024, 12:09 AM EST - 1 year ago

PROCEPT BioRobotics Corporation (PRCT) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:02 PM EST - 1 year ago

PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results

Feb 12, 2024, 4:05 PM EST - 1 year ago

PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston

Jan 8, 2024, 5:00 PM EST - 1 year ago

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

Nov 13, 2023, 4:03 PM EST - 1 year ago

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

Nov 2, 2023, 12:01 AM EDT - 2 years ago

PROCEPT BioRobotics Corporation (PRCT) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 4:02 PM EDT - 2 years ago

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

Aultreras13 Sep. 9 at 1:50 PM

$AMRC $AXL $PRCT $ULCC $ZS

0 · Reply

NVDAMillionaire Sep. 5 at 9:09 PM

0 · Reply

JasonCO Sep. 5 at 6:27 PM

$PRCT nice move from $37. Do t forget to dump or yo gonna get dumped on

1 · Reply

stockstelegraph Sep. 4 at 3:07 PM

0 · Reply

sirspanky Sep. 4 at 12:57 PM

1 · Reply

Thelonius_Stonk Sep. 3 at 5:23 PM

$PRCT show me 27s

1 · Reply

TipRanks Sep. 3 at 10:16 AM

0 · Reply

stockstelegraph Sep. 2 at 2:23 PM

0 · Reply

Muddymac Sep. 2 at 1:39 PM

$PRCT Added some more. In a quarter or two, the $40S will be in the rear view.

0 · Reply

MaverikIT Sep. 2 at 1:36 PM

$UTHR $ONC - very nice $PRCT $ARWR

0 · Reply

JarvisFlow Sep. 2 at 12:30 PM

Oppenheimer has adjusted their stance on PROCEPT BioRobotics ( $PRCT ), setting the rating to Outperform with a target price of 60.

0 · Reply

Quantumup Sep. 2 at 10:50 AM

Oppenheimer⬆️ $PRCT to Outperform/$60 from Perform. $ISRG $BSX $SYK GEHC $MDT Oppenheimer said: We are upgrading $PRCT to Outperform from Perform and establishing a $60 PT on the heels of our recent meeting with the company. We believe the stock selloff is overdone and risk-reward is quite attractive for longer-horizon growth investors. This change from our recent initiation (link) reflects: 1) reimbursement uncertainty is mitigated (good or bad) now that proposed CPT rates are out; 2) the C-suite shuffle seems more benign than originally feared; 3) the mild FY guide raise seems conservative; 4) the story's strategic appeal; and 5) enhancing HYDROS with 3D ultrasound that allows MRI fusion presents an exciting competitive advantage for next-gen device, in our view. Our $60 price target assumes ~7.7x our FY26E revenue vs. the aggregate MedTech universe at 3.9x.

0 · Reply

Quantumup Aug. 27 at 1:17 PM

Barclays🏁 $HUMA Overweight/$3.5. $MDT $BSX $JNJ $PRCT ISRG Barclays said in its initiation report:

0 · Reply

JasonCO Aug. 27 at 12:18 PM

$PRCT robotics are red hot. let’s make sure to sell that news here

0 · Reply

Muddymac Aug. 25 at 2:08 PM

$PRCT Huge buying opportunity today. I think this gets back into the $50S by Oct.

0 · Reply

Kgceltics Aug. 23 at 7:04 PM

$PRCT $TMDX tmdx owners yall like prct ? I own a lot of tmdx. Made a lot. But that one may be interesting. Not profitable. Trades at same price to sales now. Outside my wheelhouse but seems promising.

2 · Reply